Seyahian E Abril, Oltra Gisela, Ochoa Federico, Melendi Santiago, Hermes Ricardo, Paton James C, Paton Adrienne W, Lago Nestor, Castro Parodi Mauricio, Damiano Alicia, Ibarra Cristina, Zotta Elsa
Universidad de Buenos Aires, Facultad de Medicina, Instituto de Fisiología y Biofísica IFIBIO Houssay-CONICET, Argentina.
Hospital de Agudos Juan A. Fernandez, Laboratorio Central, Argentina.
Toxicon. 2017 Mar 1;127:49-55. doi: 10.1016/j.toxicon.2016.12.014. Epub 2017 Jan 3.
Subtilase cytotoxin (SubAB) is a member of the AB cytotoxin family and is produced by certain strains of Shiga toxigenic Escherichia coli. The toxin is known to be lethal to mice, but the pathological mechanisms that contribute to Uremic Hemolytic Syndrome (HUS) are poorly understood. In this study we show that intraperitoneal injection of a sublethal dose of SubAB in rats triggers a systemic response, with ascitic fluid accumulation, heart hypertrophy and damage to the liver, colon and kidney. SubAB treated rats presented microalbuminuria 20 days post inoculation. At this time we found disruption of the glomerular filtration barrier and alteration of the protein reabsorption mechanisms of the proximal tubule. In the kidney, SubAB also triggered an epithelial to mesenchymal transition (Wuyts et al., 1996). These findings indicate that apart from direct cytotoxic effects on renal tissues, SubAB causes significant damage to the other organs, with potential consequences for HUS pathogenesis.
Uremic Hemolytic Syndrome is an endemic disease in Argentina, with over 400 hundred new cases each year. We have previously described renal effects of Shiga Toxin and its ability to alter renal protein handling. Bearing in mind that Subtilase Cytotoxin is an emerging pathogenic factor, that it is not routinely searched for in patients with HUS, and that to the date its systemic effects have not been fully clarified we decided to study both its systemic effects, and its renal effects to assess whether SubAB could be contributing to pathology seen in children.
枯草杆菌蛋白酶细胞毒素(SubAB)是AB细胞毒素家族的成员,由某些产志贺毒素的大肠杆菌菌株产生。已知该毒素对小鼠具有致死性,但导致尿毒症性溶血性综合征(HUS)的病理机制尚不清楚。在本研究中,我们表明给大鼠腹腔注射亚致死剂量的SubAB会引发全身反应,出现腹水积聚、心脏肥大以及肝脏、结肠和肾脏损伤。接种后20天,接受SubAB治疗的大鼠出现微量白蛋白尿。此时我们发现肾小球滤过屏障破坏以及近端小管蛋白质重吸收机制改变。在肾脏中,SubAB还引发了上皮-间质转化(Wuyts等人,1996年)。这些发现表明,除了对肾组织的直接细胞毒性作用外,SubAB还会对其他器官造成严重损害,这可能对HUS的发病机制产生影响。
尿毒症性溶血性综合征在阿根廷是一种地方病,每年有超过400例新病例。我们之前已经描述了志贺毒素的肾脏效应及其改变肾脏蛋白质处理的能力。考虑到枯草杆菌蛋白酶细胞毒素是一种新出现的致病因素,在HUS患者中通常不进行常规检测,并且迄今为止其全身效应尚未完全阐明,我们决定研究其全身效应和肾脏效应,以评估SubAB是否可能导致儿童出现的病理情况。